Alchemi

Alchemi accelerates drug development with purpose-built scientific agents. By combining deep scientific expertise with advanced AI, our agents are built for GxP environments and streamline complex workflows across CMC, bioanalysis, clinical development, and regulatory submissions. We are already supporting >3,000 studies, helping life sciences teams bring therapies to market faster, safer, and more efficiently.[1][2]

Visit website Suggest an update

2024 Founded

Overview

Alchemi is a software development company operating in the New York City artificial intelligence sector[1]. Founded in 2024, the company develops purpose-built scientific agents designed to accelerate drug development[2]. These agents combine deep scientific expertise with advanced artificial intelligence and are built for GxP environments, streamlining workflows across CMC, bioanalysis, clinical development, and regulatory submissions[2]. According to available information, Alchemi supports more than 3,000 studies and assists life sciences teams in bringing therapies to market[2]. The company has 21 employees[3].

Growth & traction

LinkedIn lists 21 people working at Alchemi. [4]

Something wrong or missing? Send an update. Fixed within 24 hours.